Bioprocess Scale-Up Forum

pharma and biotech development pipelines now include a mix of small-molecule drugs, biologics, cell-based therapies, and vaccines (e.g., combination immune-modulatory small molecules with checkpoint antibodies). in addition to the challenges of developing and manufacturing novel therapeutics, pharma and biotechs also need to: harmonize with regulations in different countries; track world-wide inventory; and provide secure, global access to enterprise resource systems and research databases. these challenges are even more acute as pharma ramps up to offer biologics and cell-based therapies globally. addressing these challenges and pressures includes introducing new technology platforms as part of a broader, coordinated business strategy. technology leaders need remit to be flexible enough to allow innovation, while maintaining the discipline for rigorous validation and compliance. for example, one might imagine integrating in-silico process modeling for global training via ar/vr m